Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00066001 · ClinicalTrials.gov registry record · Phase 2
Microbial Associations in Periodontal Health and Disease
A Phase 2 study of Periodontal Diseases and Periodontitis, sponsored by The Forsyth Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 154
- Enrollment target
- 1
- Study location
NCT00066001: Completed Phase 2 study of Periodontal Diseases and Periodontitis, sponsored by The Forsyth Institute.
NCT00066001 is a Phase 2 study of Periodontal Diseases and Periodontitis that has completed, run by The Forsyth Institute. The registered enrollment target is 154 participants, roughly in line with the 151-participant average among 15 other Periodontal Diseases trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00066001, a Phase 2 study of Periodontal Diseases and Periodontitis, has completed, sponsored by The Forsyth Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 154 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the clinical and microbiological effects of systemically administered metronidazole alone or in combination with professional plaque removal on periodontally diseased patients.
Conditions Studied
Interventions
- DRUG metronidazole
Study Locations (1)
Massachusetts
- Department of Periodontology, The Forsyth Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2002-12 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
What the finished NCT00066001 record still lists
NCT00066001 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 151-participant average among 15 other Periodontal Diseases trials with a reported enrollment target.
The record links to 2 conditions, with Periodontal Diseases appearing as the primary indexed condition, and to 1 intervention - of which metronidazole is the first listed.
NCT00066001 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00066001 about?
NCT00066001 is a clinical study titled "Microbial Associations in Periodontal Health and Disease". The purpose of this study is to determine the clinical and microbiological effects of systemically administered metronidazole alone or in combination with professional plaque removal on periodontally diseased patients.
What is the current status of trial NCT00066001?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 154 participants. The study started on 2002-12. Estimated completion is 2009-12.
What conditions does trial NCT00066001 study?
This clinical trial studies the following conditions: Periodontal Diseases, Periodontitis.
What interventions are being tested in trial NCT00066001?
The interventions under investigation include: metronidazole (DRUG).
Who is sponsoring clinical trial NCT00066001?
This trial is sponsored by The Forsyth Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00066001 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Periodontal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00066001's enrollment target sits among peer trials
154 4th of 15 higher than 12 of 15 other Periodontal Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Periodontal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study Comparing Two Different Methods of Treating Periodontal Disease
COMPLETED · Phase 2
-
Changes in Microbial Status From Dentate, Edentulous and After Dental Implant Placement
RECRUITING
-
Novel Dental Gel as an Adjunct to Scaling and Root Planing
RECRUITING · NA
-
Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice
RECRUITING · Phase 3
-
Oral Health Intervention in Adult Primary Care
RECRUITING · NA
-
An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia